These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Severe hypertrichosis in infants due to transdermic exposure to 5% and 7% topical minoxidil. Rica Echevarría I; García Del Monte J; Delgado Rubio A; Arcangeli F; Lotti T Dermatol Ther; 2020 Nov; 33(6):e14230. PubMed ID: 32844481 [TBL] [Abstract][Full Text] [Related]
8. Piggyback-acquired hypertrichosis. Farsani TT; Kane MJ; Kane KS Pediatr Dermatol; 2014; 31(4):520-2. PubMed ID: 24915767 [TBL] [Abstract][Full Text] [Related]
9. A child with generalized hypertrichosis due to secondary topical minoxidil exposure. Maltoni G; Cedirian S; Scozzarella A; Bernardini L; Piraccini BM; Starace M Pediatr Dermatol; 2023; 40(4):753-754. PubMed ID: 37042338 [TBL] [Abstract][Full Text] [Related]
10. Generalized Hypertrichosis Due to Topical Minoxidil. Gargallo V; Gutierrez C; Vanaclocha F; Guerra-Tapia A Actas Dermosifiliogr; 2015 Sep; 106(7):599-600. PubMed ID: 25688008 [No Abstract] [Full Text] [Related]
11. Oral bicalutamide for female pattern hair loss: A pilot study. Fernandez-Nieto D; Saceda-Corralo D; Rodrigues-Barata R; Hermosa-Gelbard A; Moreno-Arrones O; Jimenez-Cauhe J; Ortega-Quijano D; Vano-Galvan S Dermatol Ther; 2019 Nov; 32(6):e13096. PubMed ID: 31579984 [No Abstract] [Full Text] [Related]
12. Safety of oral bicalutamide in female pattern hair loss: A retrospective review of 316 patients. Ismail FF; Meah N; Trindade de Carvalho L; Bhoyrul B; Wall D; Sinclair R J Am Acad Dermatol; 2020 Nov; 83(5):1478-1479. PubMed ID: 32213304 [No Abstract] [Full Text] [Related]
13. Systemic minoxidil for hair disorders in pediatric patients: a safety and tolerability review. John JM; Sinclair RD Int J Dermatol; 2023 Feb; 62(2):257-259. PubMed ID: 35965281 [TBL] [Abstract][Full Text] [Related]
14. Minoxidil induced hypertrichosis in children. Guerouaz N; Mohamed AO Pan Afr Med J; 2014; 18():8. PubMed ID: 25360192 [No Abstract] [Full Text] [Related]
15. Infantile generalized hypertrichosis caused by topical minoxidil. Rampon G; Henkin C; de Souza PR; Almeida HL An Bras Dermatol; 2016; 91(1):87-8. PubMed ID: 26982785 [TBL] [Abstract][Full Text] [Related]
16. Bicalutamide: A potential new oral antiandrogenic drug for female pattern hair loss. Fernandez-Nieto D; Saceda-Corralo D; Jimenez-Cauhe J; Moreno-Arrones OM; Rodrigues-Barata R; Hermosa-Gelbard A; Vano-Galvan S J Am Acad Dermatol; 2020 Nov; 83(5):e355-e356. PubMed ID: 32320770 [No Abstract] [Full Text] [Related]
17. Topical minoxidil for hair loss in women. Hong D; Hart LL DICP; 1990 Nov; 24(11):1062-3. PubMed ID: 2275230 [No Abstract] [Full Text] [Related]
18. Generalized hypertrichosis after treatment with topical minoxidil. González M; Landa N; Gardeazabal J; Calderón MJ; Bilbao I; Díaz Pérez JL Clin Exp Dermatol; 1994 Mar; 19(2):157-8. PubMed ID: 8050148 [TBL] [Abstract][Full Text] [Related]
19. RF - Bicalutamide: An Emergent Treatment Option in Trichology. Pegalajar-García MD; Gil-Villalba A; de la Torre-Gomar FJ Actas Dermosifiliogr; 2023 Oct; 114(9):812-815. PubMed ID: 37343820 [No Abstract] [Full Text] [Related]
20. Hypertrichosis in females applying minoxidil topical solution and in normal controls. Dawber RP; Rundegren J J Eur Acad Dermatol Venereol; 2003 May; 17(3):271-5. PubMed ID: 12702063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]